Clinical and radiographic evaluation of zinc oxide eugenol (ZOE) and iodoform-calcium hydroxide (Metapex) as filling materials in primary molar root canals
Carious Primary Molars Indicated for Pulpectomy
Enrolment: 44 · Results not recorded
Nutraceutical
0 linked trials carry an injury-indication flag. These flags support record-level exploration and sit alongside the stringent aggregate counts described in Methods.
Carious Primary Molars Indicated for Pulpectomy
Enrolment: 44 · Results not recorded
2 studies reported at therapy level; 2 evidence entries itemised.
Model: Lipopolysaccharide-induced acute lung injury, with lung mechanics and histology analysed 24 h after exposure
Eugenol improved lipopolysaccharide-induced lung functional and histological changes in a dose-dependent way, and at 150 mg/kg inhibited release of inflammatory cytokines, NADPH oxidase activity and protein oxidation.
Extraction: extract · Supplied extraction confidence: 0.6. Machine-extracted fields require source verification.
Model: Arsenic trioxide-induced cardiotoxicity, arsenic trioxide 4 mg/kg body weight
Eugenol maintained tissue antioxidant levels and ATPase activity, normalised cytosolic ion levels, reduced membrane peroxidation, restored heart rate and corrected QT prolongation, with histology supporting protection against arsenic-induced oxidative damage.
Extraction: extract · Supplied extraction confidence: 0.7. Machine-extracted fields require source verification.